Best Stocks Under $2 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Stardust Power NASDAQ:SDST$0.51 +0.00 (+0.85%) Closing price 04:00 PM EasternExtended Trading$0.49 -0.02 (-4.31%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$29.53 millionConsensus RatingBuyConsensus Price Target$5.11 (+902.5% Upside)Volume248,390 sharesAverage Volume359,629 sharesToday's Range$0.42▼$0.52 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. OS Therapies NYSE:OSTX$1.43 +0.03 (+2.14%) Closing price 04:00 PM EasternExtended Trading$1.41 -0.02 (-1.47%) As of 05:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS TherapiesMarket Capitalization$30.98 millionConsensus RatingBuyConsensus Price Target$18.00 (+1,158.7% Upside)Volume131,864 sharesAverage Volume1.12 million sharesToday's Range$1.36▼$1.463. Denison Mines NYSEAMERICAN:DNN$1.18 -0.01 (-0.84%) Closing price 04:10 PM EasternExtended Trading$1.18 0.00 (0.00%) As of 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.06 billionP/E Ratio-118.00Consensus RatingBuyConsensus Price Target$3.00 (+154.2% Upside)Volume106.86 million sharesAverage Volume53.17 million shares4. enCore Energy NASDAQ:EU$1.19 +0.03 (+2.59%) Closing price 04:00 PM EasternExtended Trading$1.18 -0.01 (-1.26%) As of 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$221.80 millionP/E Ratio-4.25Consensus RatingBuyConsensus Price Target$4.38 (+267.6% Upside)Volume2.60 million sharesAverage Volume1.45 million shares5. Cardiol Therapeutics NASDAQ:CRDL$0.85 +0.04 (+4.94%) Closing price 04:00 PM EasternExtended Trading$0.90 +0.05 (+6.00%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$70.22 millionP/E Ratio-2.18Consensus RatingBuyConsensus Price Target$8.40 (+888.2% Upside)Volume453,254 sharesAverage Volume385,168 shares6. Reviva Pharmaceuticals NASDAQ:RVPH$0.60 +0.07 (+13.21%) Closing price 04:00 PM EasternExtended Trading$0.59 -0.01 (-2.00%) As of 05:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$20.07 millionP/E Ratio-0.54Consensus RatingBuyConsensus Price Target$10.00 (+1,566.7% Upside)Volume862,384 sharesAverage Volume1.10 million sharesRemove Ads7. GeoVax Labs NASDAQ:GOVX$0.95 -0.07 (-6.66%) As of 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$8.98 millionP/E Ratio-0.17Consensus RatingBuyConsensus Price Target$14.20 (+1,391.4% Upside)Volume345,918 sharesAverage Volume603,179 shares8. Quince Therapeutics NASDAQ:QNCX$1.22 -0.02 (-1.61%) Closing price 04:00 PM EasternExtended Trading$1.21 -0.01 (-0.82%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$53.68 millionP/E Ratio-0.98Consensus RatingBuyConsensus Price Target$8.00 (+555.7% Upside)Volume163,029 sharesAverage Volume245,264 shares9. Nkarta NASDAQ:NKTX$1.56 -0.07 (-4.29%) Closing price 04:00 PM EasternExtended Trading$1.54 -0.02 (-0.96%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$110.69 millionP/E Ratio-0.83Consensus RatingBuyConsensus Price Target$14.86 (+852.4% Upside)Volume1.20 million sharesAverage Volume1.10 million shares10. Mereo BioPharma Group NASDAQ:MREO$1.83 -0.16 (-8.04%) Closing price 04:00 PM EasternExtended Trading$1.84 +0.01 (+0.55%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$283.92 millionP/E Ratio-30.50Consensus RatingBuyConsensus Price Target$7.71 (+321.5% Upside)Volume2.78 million sharesAverage Volume1.03 million shares11. Immunic NASDAQ:IMUX$0.94 -0.05 (-5.21%) Closing price 04:00 PM EasternExtended Trading$0.95 +0.01 (+0.72%) As of 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$85.03 millionP/E Ratio-0.77Consensus RatingBuyConsensus Price Target$13.20 (+1,299.5% Upside)Volume769,046 sharesAverage Volume614,790 sharesRemove Ads12. Rezolve AI NASDAQ:RZLV$1.28 -0.01 (-0.78%) Closing price 04:00 PM EasternExtended Trading$1.28 +0.00 (+0.39%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$220.39 millionConsensus RatingBuyConsensus Price Target$6.00 (+368.8% Upside)Volume2.39 million sharesAverage Volume5.17 million sharesToday's Range$1.17▼$1.3813. Lucid Diagnostics NASDAQ:LUCD$1.55 +0.11 (+7.64%) Closing price 04:00 PM EasternExtended Trading$1.55 0.00 (0.00%) As of 05:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$140.67 millionP/E Ratio-1.36Consensus RatingBuyConsensus Price Target$3.40 (+119.4% Upside)Volume1.88 million sharesAverage Volume377,990 shares14. PMV Pharmaceuticals NASDAQ:PMVP$0.96 -0.04 (-4.00%) Closing price 04:00 PM EasternExtended Trading$0.96 0.00 (-0.42%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV PharmaceuticalsMarket Capitalization$49.86 millionP/E Ratio-0.96Consensus RatingBuyConsensus Price Target$5.50 (+472.9% Upside)Volume129,681 sharesAverage Volume271,770 shares15. Western Copper & Gold NYSE:WRN$0.94 -0.03 (-3.08%) As of 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$188.02 millionP/E Ratio-47.01Consensus RatingBuyConsensus Price Target$4.25 (+352.1% Upside)Volume445,124 sharesAverage Volume303,516 shares16. NRx Pharmaceuticals NASDAQ:NRXP$1.81 +0.02 (+1.12%) Closing price 04:00 PM EasternExtended Trading$1.77 -0.04 (-2.21%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx PharmaceuticalsMarket Capitalization$30.62 millionP/E Ratio-0.85Consensus RatingBuyConsensus Price Target$28.25 (+1,460.8% Upside)Volume241,440 sharesAverage Volume452,174 sharesRemove Ads17. FibroBiologics NASDAQ:FBLG$0.87 -0.01 (-0.72%) Closing price 04:00 PM EasternExtended Trading$0.84 -0.03 (-3.90%) As of 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$32.83 millionP/E Ratio-2.56Consensus RatingBuyConsensus Price Target$13.00 (+1,394.4% Upside)Volume182,065 sharesAverage Volume278,428 shares18. HIVE Digital Technologies NASDAQ:HIVE$1.42 +0.02 (+1.43%) Closing price 04:00 PM EasternExtended Trading$1.46 +0.04 (+2.46%) As of 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital TechnologiesMarket Capitalization$233.72 millionP/E Ratio-28.40Consensus RatingBuyConsensus Price Target$7.64 (+438.2% Upside)Volume8.05 million sharesAverage Volume5.87 million shares19. Perspective Therapeutics NYSE:CATX$1.80 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.78 -0.03 (-1.39%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective TherapeuticsMarket Capitalization$133.29 millionConsensus RatingBuyConsensus Price Target$13.22 (+634.6% Upside)Volume1.16 million sharesAverage Volume804,779 sharesToday's Range$1.62▼$1.8920. ProQR Therapeutics NASDAQ:PRQR$1.17 -0.01 (-0.85%) Closing price 04:00 PM EasternExtended Trading$1.18 +0.02 (+1.28%) As of 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR TherapeuticsMarket Capitalization$123.10 millionP/E Ratio-3.66Consensus RatingBuyConsensus Price Target$9.50 (+712.0% Upside)Volume438,227 sharesAverage Volume572,171 shares21. Gain Therapeutics NASDAQ:GANX$1.65 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.70 +0.05 (+3.03%) As of 05:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$45.85 millionP/E Ratio-1.50Consensus RatingBuyConsensus Price Target$8.20 (+397.0% Upside)Volume325,526 sharesAverage Volume245,199 shares22. Lexeo Therapeutics NASDAQ:LXEO$1.79 -0.55 (-23.50%) Closing price 04:00 PM EasternExtended Trading$1.84 +0.05 (+2.79%) As of 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo TherapeuticsMarket Capitalization$59.42 millionP/E Ratio-0.57Consensus RatingBuyConsensus Price Target$22.80 (+1,173.7% Upside)Volume5.88 million sharesAverage Volume376,754 shares23. Rani Therapeutics NASDAQ:RANI$1.12 -0.09 (-7.44%) Closing price 04:00 PM EasternExtended Trading$1.14 +0.02 (+2.23%) As of 05:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani TherapeuticsMarket Capitalization$64.16 millionP/E Ratio-1.06Consensus RatingBuyConsensus Price Target$12.33 (+1,001.2% Upside)Volume341,715 sharesAverage Volume749,620 shares24. Context Therapeutics NASDAQ:CNTX$0.60 +0.01 (+0.98%) Closing price 04:00 PM EasternExtended Trading$0.58 -0.02 (-3.64%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$54.27 millionP/E Ratio-0.66Consensus RatingBuyConsensus Price Target$6.17 (+919.3% Upside)Volume141,484 sharesAverage Volume402,374 shares25. Zura Bio NASDAQ:ZURA$1.15 +0.12 (+11.65%) Closing price 04:00 PM EasternExtended Trading$1.15 0.00 (0.00%) As of 05:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. More about Zura BioMarket Capitalization$75.09 millionP/E Ratio-2.17Consensus RatingBuyConsensus Price Target$14.67 (+1,175.4% Upside)Volume731,789 sharesAverage Volume383,662 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Options Activity Points to More Volatility for Palantir Stock NVIDIA Stock: Oversold, Undervalued — How Low Can It Go? MicroStrategy Sees Insider Buy-Sell Action in Q1 Springing Dividends: 3 Dividend Boosters to Watch Now Taiwan Semiconductor Spared From New Tariffs: Bullish Path Ahead? MarketBeat Week in Review – 03/31 - 04/04 Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential? AI Takes Over Search: Is Google's Dominance At Risk? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
